Cyclacel Pharmaceuticals ... (CYCC)
0.33
-0.00 (-0.45%)
At close: Mar 03, 2025, 11:54 AM
Cyclacel Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| Cash & Equivalents | 3.38M | 18.34M | 36.56M | 33.41M | 11.88M | 17.5M | 23.91M | 16.52M | 20.44M | 24.19M | 31.15M | 16.41M | 24.45M | 29.5M | 11.49M | 24.22M | 30.99M | 44.24M | 13.6M | 13.9M | 2.24M | n/a | n/a | n/a |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 132K | 132K | 132K | 132K | 132K | 153K | n/a | n/a | n/a | 1.5M | 27.77M | 9.76M | 6.93M | 33.42M | 11.3M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.26M | 2.92M | 1.55M | -1.33M | -1.29M | n/a | n/a | n/a | n/a | n/a | 72K | 353K | n/a | n/a | 196K | 195K | 196K | 241K | 347K | 1.06M | 1.67M | n/a | n/a | n/a |
| Receivables | 2.93M | n/a | n/a | 1.31M | 1.33M | n/a | n/a | 2.06M | 3.03M | 3.46M | 2.31M | n/a | n/a | n/a | n/a | n/a | 2.47M | 2.48M | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | -5.64M | 577K | 684K | 703K | 609K | 495K | 999K | 968K | 1.07M | 3.03M | n/a | 182K | 174K | 145K | 508K | 213K | 1.37M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.13M | 7.04M | 4.38M | 750K | 806K | 2.28M | 1.93M | 1.04M | 1.1M | 1.35M | 1.72M | 2.46M | 1.2M | 1.38M | 1.73M | 2.78M | 2.34M | 4.06M | 3.22M | 1.02M | 519K | n/a | n/a | n/a |
| Total Current Assets | 7.44M | 24.41M | 40.94M | 35.47M | 14.02M | 19.79M | 25.97M | 19.62M | 24.57M | 29M | 35.17M | 18.87M | 25.83M | 31.05M | 13.37M | 29.01M | 63.78M | 58.16M | 20.92M | 48.34M | 14.06M | n/a | n/a | n/a |
| Property-Plant & Equipment | 102K | 174K | 94K | 1.33M | 1.29M | 36K | 29K | 45K | 198K | 387K | 275K | 129K | 167K | 408K | 901K | 1.75M | 3.02M | 2.12M | 176K | 6.21M | 2.77M | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.92M | 2.75M | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.36M | 3.09M | 1.65M | 1.33M | 1.29M | 36K | 29K | 45K | 198K | 387K | 347K | 482K | 167K | 408K | 1.1M | 1.94M | 12.13M | 5.11M | 523K | 7.26M | 4.44M | n/a | n/a | n/a |
| Total Assets | 8.8M | 27.5M | 42.59M | 36.8M | 15.31M | 19.82M | 26M | 19.66M | 24.76M | 29.39M | 35.52M | 19.35M | 26M | 31.46M | 14.47M | 30.96M | 75.91M | 63.28M | 21.45M | 55.6M | 18.5M | 21.54M | 24.73M | 28.48M |
| Account Payables | 3.54M | 2.56M | 2.12M | 514K | 890K | 2.72M | 1.56M | 2.5M | 1.94M | 2.79M | 2.54M | 2.26M | 1.72M | 1.72M | 1.71M | 754K | 4.96M | 2.17M | 2.16M | 1.71M | 954K | n/a | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 150K | 150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.23M | n/a | 47K | 1.26M | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 89K | 251K | 1.56M | 12.5M | n/a | n/a | n/a |
| Other Current Liabilities | 4.62M | 4.95M | 3.18M | 1.97M | 1.53M | 1.73M | 2.56M | 2.76M | 3.81M | 4.7M | 4.95M | 7.08M | 4.78M | 4.81M | 8.11M | 7.87M | 9.75M | 5.66M | 2.81M | 4.1M | 1.26M | n/a | n/a | n/a |
| Total Current Liabilities | 8.16M | 7.39M | 5.29M | 2.49M | 2.42M | 4.45M | 4.11M | 5.26M | 5.75M | 7.49M | 7.5M | 9.34M | 6.5M | 6.54M | 9.82M | 8.63M | 14.71M | 7.92M | 5.22M | 7.41M | 14.71M | n/a | n/a | n/a |
| Long-Term Debt | 37K | 106K | 30K | 1.06M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 626K | n/a | n/a | 78K | 2.68M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 100K | 124K | 130K | 176K | 206K | n/a | n/a | n/a | n/a | n/a | 1.06M | 3.23M | 1.44M | 1.54M | 631K | 68.63M | n/a | n/a | n/a |
| Total Long-Term Liabilities | 37K | 4.6M | 30K | 1.06M | 1.19M | 100K | 124K | 130K | 176K | 206K | n/a | n/a | n/a | n/a | n/a | 1.69M | 3.23M | 1.44M | 1.62M | 4.07M | 68.63M | n/a | n/a | n/a |
| Total Liabilities | 8.2M | 11.99M | 5.32M | 3.54M | 3.61M | 4.55M | 4.24M | 5.39M | 5.93M | 7.7M | 7.5M | 9.34M | 6.5M | 6.54M | 9.82M | 10.31M | 17.94M | 9.36M | 6.84M | 11.48M | 83.34M | 69.66M | 60.99M | 53.86M |
| Total Debt | 37K | 106K | 30K | 1.06M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 626K | 10K | 89K | 2.07M | 4.23M | 11.65M | n/a | n/a | n/a |
| Common Stock | 1K | 4.5M | 10K | 6K | 17K | 12K | 12K | 4K | 35K | 23K | 19K | 9K | 54K | 47K | 26K | 20K | 20K | 16K | 19K | 19K | 2K | n/a | n/a | n/a |
| Retained Earnings | -428.28M | -406.16M | -384.96M | -366.07M | -357.63M | -349.8M | -342.51M | -335.04M | -323.16M | -308.82M | -289.43M | -270.25M | -257.06M | -241.82M | -222.28M | -202.72M | -162.33M | -138.28M | -155.6M | -126.18M | -86.59M | -68.14M | -48.69M | -29.17M |
| Comprehensive Income | -908K | -1.32M | -748K | -746K | -819K | -760K | -794K | -743K | -596K | -480K | -109K | 48K | 57K | 31K | 20K | -42K | -2.63M | -2.54M | -193K | -1.43M | -2.78M | n/a | n/a | n/a |
| Shareholders Equity | 607K | 15.51M | 37.26M | 33.26M | 11.7M | 15.27M | 21.77M | 14.27M | 18.84M | 21.69M | 28.02M | 10.02M | 19.5M | 24.92M | 4.64M | 20.64M | 57.97M | 53.92M | 14.6M | 44.12M | -64.84M | -48.13M | -36.26M | -25.38M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | 132K | 132K | 132K | 132K | 132K | 153K | n/a | n/a | n/a | 1.5M | 27.77M | 9.76M | 6.93M | 33.42M | 11.3M | n/a | n/a | n/a |